Incorporation increasing of Daunorubicin adding by Titanium dioxide Nanopatricles for cancer therapy

来源 :第二十二届浙江省肿瘤防治学术年会 | 被引量 : 0次 | 上传用户:hewei83221
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Titanium dioxide nanoparticleswhich are well known with their photocatalytic activity have become one of the most potential nanomaterialsapplied in environmental scientific research and clinical exploring fields.To evaluate the effect of drug delivery carrier role of titanium dioxide nanoparticles combined with anticancer drug,daunorubicin.on cancer cells.fluorescence microscopy.MTT and FCM assay have been explored in this study.Our observations demonstrate that compared with the effect of daunorubicin alone,the intracellular concentrations of daunorubicin in cancer cells like liver SMMC-7721 cancer ceils obviously increase in the presence of titanium dioxide nanoparticles.Besides,it is observed that the ultra violent illumination can further enhance the lethality of cancer cells.These results indicate that the titanium dioxide nanoparticles can act as an efficient carrier for drug delivery to increase the uptake of drugs and hence lessen the toxic side effects.Thus.it is evident that this new combination of titanium dioxide nanoparticles and anticancer drugs could be utilized as an optimal strategy for their promising biomedical application in cancer therapy.
其他文献
会议
会议
会议
会议
会议
目的:探讨手助腹腔镜手术在结直肠癌根治术中的应用经验及临床效果.方法:回顾性分析本中心2009年8月-2010年4月实施的111例手助腹腔镜结直肠癌根治术患者的临床资料.结果:111例手术中,顺利完成108例,另3例中转开腹(2.7%);平均手术时间(155±45) min,术中出血量(129±80) ml;术后肠功能恢复时间(65.4±10.1)h,术后平均住院时间(10.6±2.2)d;平均淋
目的 建立异基因骨髓移植小鼠移植物抗宿主病(GVHD)模型,寻找最适清髓的照射剂量,为研究GVHD的发病机制提供实验平台.方法分别使用Balb/c、C57BL/6小鼠作为供受者相互间进行异基因骨髓移植,移植小鼠置于洁净动物房饲养,移植前一周给予含庆大霉素的饮用水,受鼠接受照射源60Co全身照射,照射总剂量分别采用6.5、7、7.5、8、8.5、9、10、11Gy,剂量率用0.8Gy/min和1.6
目的:探讨食管癌根治性治疗后局部复发多学科综合治疗疗效及预后因素.材料与方法:回顾性分析196例食管癌根治性治疗后局部复发患者临床特点,结合随访资料进行预后因素分析,用Kaplan-Meier法和Logrank法分析比较生存率,用Cox模型进行多因素回归分析.结果:全组中位生存时间8.0个月(95% CI 6.7~9.3个月),总的1、2、3年生存率分别为29.8%、5.9%、4.0%.单因素分析
目的:分析胸段食管鳞癌淋巴结转移规律,探讨其预防性放疗适应症及范围.材料与方法:对自2005年1月至2009年12月收治浙江省肿瘤医院的1301例胸段食管癌根治性手术患者的临床资料进行回顾性分析,剔除食管癌分段不明确(中上段、中下段)、病理为非鳞癌、以及转移淋巴结部位标记不清的患者.符合条件的有907例(其中行三切口手术130例),分析其淋巴结转移规律,并用单因素和多因素回归分析研究临床病理因素对
All-trans retinoic acid (ATRA) has been successfully used in differentiation therapy for acute promyelocytic leukemia (APL) in clinic.ATRA-induced differentiation of leukemia cells is accompanied with